BI-9564
Drug Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BI-9564 |
| Trade Name | |
| Synonyms | BI9564|BI 9564 |
| Drug Descriptions |
BI-9564 is a selective BRD9 inhibitor that also has activity against BRD7 and CECR2, which has potential antitumor activity (PMID: 31000582, PMID: 26749027, PMID: 26914985). |
| DrugClasses | |
| CAS Registry Number | 1883429-22-8 |
| NCIT ID | NA |
Filtering
- Case insensitive filtering will display rows if any text in any cell matches the filter term
- Use simple literal full or partial string matches
- Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
- Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
- Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")
Sorting
- Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
- Click on any column header arrows to sort by that column
- Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BAZ2-ICR + BI-9564 + JQ1 | BAZ2-ICR BI-9564 JQ1 | 0 | 0 |
| BI-9564 | BI-9564 | 0 | 0 |
CKB BOOST